A Study On A Wave Amplitude And Positive Panss Scores

In an attempt to gain a position as a psychologist, I will be discussing schizophrenia and the disorder’s casual factors, associated symptoms, the areas of the brain it affects, and the neural basis of the disorder. I will continue on to discuss appropriate drug therapies. In addition I will also be reviewing two separate case studies, each on a different disorder. I will be examining each problem from the perspective of a bio psychologist. I will define the patient’s diagnosis at length I will relate each case to the nature-nurture theory, and talk about any helpful drug interventions or solutions for each disorder. When talking about drug intervention, it is also important to discuss the positive and

Outline and evaluate one or more biological explanations of schizophrenia (8 marks AO1/16 marks AO1)

Expert’s reason that unevenness in the complicated interconnected chemical responses of the brain connecting the neurotransmitters dopamine and glutamate, and maybe others, performs a part in schizophrenia. Neurotransmitters are elements that permit brain cells to interconnect with each other. Experts are acquiring more about brain chemistry and its connection to schizophrenia. Similarly, in small methods the brains of people with schizophrenia appear diverse than those of healthful people. For instance, fluid-filled holes at the middle of the brain, called ventricles, are greater in certain people with schizophrenia. The brains of people with the disorder similarly manage to have less grey matter, and certain

Research by Johnstone in 1994, explained the biological approach of interventions, explanation and treating of schizophrenia patients (Hansell & Damour, 2005). In studies of Fisher in 2001, discoveries that the brain had more dopamine receptors know as B_2 receptors in a person suffering from schizophrenia, than a non-suffer (Hansell & Damour, 2005). Biological findings of schizophrenia suggest that a genetic factor was hereditary, but not conclusive because the element of environment does make a difference (Hansell & Damour, 2005).

Schizophrenia is a complex and highly debilitating mental illness that we are currently unable to treat in any way that guarantees success or return to previous function. It affects around 1% of the population and is associated with a thirteen-fold increase in the likelihood of suicide, so its effective control is paramount (Gogos et al., 2015). There have been several hypotheses as to the cause of schizophrenia. Many link genetic and environmental factors, and dysregulations of neurotransmitters dopamine, glutamate, and serotonin (Egbujo, Sinclair, & Hahn, 2016). The dopamine hypothesis currently suggests that hyperactive dopamine transmission in the basal ganglia leads to psychosis and underactive dopamine transmission in the prefrontal

Schizophrenia is a psychological disease with an unknown treatment. Its onset starts in early adult hood on average. There are many studies showing links to genetics and environmental causes. In this paper I will discuss many of the signs and symptoms of schizophrenia along with how it is diagnosed, imaged with MRI, and the difficulty in treating this disease. More treatments for schizophrenia may be revealed with the further advancement of imaging technology. Schizophrenia is a disease that affects the most complex structure in the human body, the human brain. The more research that is continued on the smaller segments of the different areas of the brain with imaging modalities the closer we get to

It was believed a seizure in the brain caused by the electric current would stimulate the release of neurotransmitters, and would allow the brain to reorganize to function correctly (Nasar). Neurotransmitters are chemical substances that transmit signals that facilitate cell to cell communication throughout the nervous system, and play a key component in the biological paradigm for treatment of schizophrenia. At this early stage of understanding schizophrenia’s pathology, it was believed these chemicals were imbalanced and shocking the brain would force a rebalance of these vital chemicals. Once rebalanced, it was hypothesized the patient would no longer suffer from schizophrenia (Tharyan, 2005). The insight into treating neurotransmitter imbalances in patients diagnosed with schizophrenia began the treatment path to present day antipsychotic pharmaceutical drug therapy. While the actual effects of electroshock therapy on patients with schizophrenia are unclear, it is still used today to treat schizophrenic patients who are resistant to pharmaceutical drug therapy. Electroshock therapy was the utilization of insulin coma therapy and electroshock therapy to treat schizophrenia were successful partly due to the required hospital admittance and doctor administered methodology. In both treatments the patients were required to be admitted into a hospital and were not responsible for administering the treatment themselves. While both treatment methods were viewed as inhumane and

The major support and refutation of the dopamine hypothesis has come from the examination of dopamine receptors in these regions of the brain. There are two main types of dopamine receptors, D1 and D2. However, within the category of D2 receptors, there are three subtypes, D2, D3, and D4. (5) Through PET scan analysis of dopamine usage in the brain and post-mordum molecular analysis of brain tissue, researcher were able to determine relative levels of dopamine receptors in patients with schizophrenia compared to non-schizophrenics. Overall analysis of dopamine

Patients with schizophrenia resulted to having antibodies in their systems while the other group did not. (Grison, Heatherton, and Gazzaniga, 2015, p. 521). Other researchers have presented arguments of their being abnormalities in the neural transmitters. (Grison, Heatherton, and Gazzaniga, 2015, p. 521). Dopamine is one neural transmitter researchers have taken a major interest in because medication given to schizophrenics blocking the dopamine transmitters seem to help calm the severity of the symptoms of a wide number of patients. Although doctors are not yet certain of the cause of schizophrenia they are certain of the fact that people with schizophrenia have less brain tissue due to having large ventricles.

Biological theorists believe that individuals may have a genetic predisposition for the schizophrenia if a close family member has been diagnosed with the disorder. Stress during adolescent years seems to provoke the disorder among individuals who have a family history of the disorder. In addition, this theory suggests biochemical abnormalities related to the dopamine neurotransmitters may also contribute to the illness as the brains neurotransmission of the dopamine is too frequent in occurrence (Comer, 2005). CAT and MRI scans have also indicated that abnormal brain structuring may also play a role in the development of schizophrenia due to a common occurrence of enlarged ventricles within schizophrenia sufferers (Comer, 2005). Various parts of the brain may not develop for function properly which seems lead to Type II schizophrenia. Studies have also pointed towards the idea that exposure to certain viruses before birth may lead to the eventual development of schizophrenia (Comer, 2005).

The results of these earlier studies were expounded on by research that suggested increased striatal dopamine

In the research presented by Howes and Kapur (2009), they have pointed out a possible concern to invalidate the dopamine hypothesis in schizophrenia as current PET studies did not holding a firm position in measure the dopamine level, they were more to a postulation of a generated estimation from the data. Furthermore, Howes and Kapur (2009) also stressed that the role of dopamine could be circumvented by using the antipsychotic drugs which effectively to the psychotic symptoms but neutral to the dopamine system, thus the role of dopamine will be less critical in schizophrenia. This is because most of the recent antipsychotic researches only prove that dopamine merely contributed in providing a solution in alleviating the psychosis-liked-symptoms but those symptoms are not the symptoms only existed in schizophrenia.

The Dopamine Hypothesis theorizes that the symptoms portrayed in Schizophrenia is can be explained by abnormal function of dopamine in the brain. There have been three versions of the Dopamine Hypothesis. The first version of the hypothesis focuses on the dopamine receptors. Antipsychotic drugs that impact the metabolization and reabsorption of dopamine where found to be effective in treating the symptoms. It was theorized that if the symptoms of a Schizophrenic episode can be treated by the use of dopamine

Carl Jung suggested that the presence of toxin x a mystery chemical that he though would eventually be identified. The demonstrated role of genetic factors in schizophrenia also suggested that biochemical’s should be investigated for it is the body chemistry and physiological processes that heredity may have an effect. (G, Davison, J, M,

Also known as polyunsaturated fatty acids (PUFAs), Omega-3s play a critical role in brain function and in normal growth and development.